PD Dr. Julia-Tatjana Maul is a senior physician in the Department of Dermatology at the University Hospital of Zürich, Switzerland. She was elected as the head of the clinical trials team and is the leading physician of the psoriasis and hidradenitis suppurativa clinic. PD Dr. Maul is the principal investigator (PI) of several clinical trials such as the national Swiss psoriasis registry SDNTT (Swiss Dermatology Network for Targeted Therapy) and the International pustular psoriasis registry IRASPEN. PD Dr. Maul graduated from the Medical School at the University of Tübingen, Germany in 2011. Between 2011 and 2013, she did part of her residency in the Oncology Department at the University Hospital of Zürich, Switzerland prior to transitioning to the Dermatology Department. PD Dr. Maul’s main research activities are focused on psoriasis by investigating the drug survival of biologics and conventional systemics, gender differences in treatment response and access to treatment. She holds a leadership position at the Global Psoriasis Atlas (GPA) as the Global Medical Coordinator. Furthermore, she is involved in the European Psoriasis Guidelines and co-authored the chapters cancer, pregnancy, and diabetes.